Is APLIF or GBDC a better dividend investment in 2026?

APLIF currently yields 18181.82% with a 5% 5-year dividend growth rate. GBDC yields 11.85% with 5% growth. The better choice depends on your goal: APLIF offers higher current income.

What is the dividend yield difference between APLIF and GBDC?

APLIF has a forward dividend yield of 18181.82% ($2.00/share annually). GBDC yields 11.85% ($1.50/share annually). The yield gap is 18169.97 percentage points.

Home › Compare › APLIF vs GBDC

APLIF vs GBDC: Dividend Comparison 2026

APLIF yields 18181.82% · GBDC yields 11.85%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 APLIF wins by $20382968138483965952.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

APLIF

● Live price

18181.82%

Share price

$0.01

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20382968138483965952.00M

Annual income

$20,164,798,479,641,134,000,000,000.00

Full APLIF calculator →

GBDC

● Live price

11.85%

Share price

$12.66

Annual div

$1.50

5Y div CAGR

51.1%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.78M

Annual income

$16,389,263.41

Full GBDC calculator →

Portfolio growth — APLIF vs GBDC

📍 APLIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	APLIF	GBDC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, APLIF + GBDC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

APLIF pays

GBDC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APLIF

Annual income on $10K today (after 15% tax)

$1,545,454.55/yr

After 10yr DRIP, annual income (after tax)

$17,140,078,707,694,964,000,000,000.00/yr

GBDC

Annual income on $10K today (after 15% tax)

$1,007.11/yr

After 10yr DRIP, annual income (after tax)

$13,930,873.90/yr

At 15% tax rate, APLIF beats the other by $17,140,078,707,694,964,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APLIF + GBDC for your $10,000?

APLIF: 50%GBDC: 50%

100% GBDC50/50100% APLIF

Portfolio after 10yr

$10191484069241982976.00M

Annual income

$10,082,399,239,820,567,000,000,000.00/yr

Blended yield

98.93%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

APLIF

No analyst data

Altman Z

-234.9

Piotroski

4/9

GBDC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$14.00

+10.6% upside vs current

Range: $13.00 — $15.00

Altman Z

0.6

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APLIF buys

GBDC buys

No recent congressional trades found for APLIF or GBDC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAPLIFGBDC

Forward yield	18181.82% ✓	11.85%
Annual dividend / share	$2.00 ✓	$1.50
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	51.1% ✓
Portfolio after 10y	$20382968138483965952.00M ✓	$20.78M
Annual income after 10y	$20,164,798,479,641,134,000,000,000.00 ✓	$16,389,263.41
Total dividends collected	$20368560651224936448.00M ✓	$20.36M
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: APLIF vs GBDC ($10,000, DRIP)

Year	APLIF Portfolio	APLIF Income/yr	GBDC Portfolio	GBDC Income/yr	Gap
1← crossover	$1,828,882	$1,818,181.82	$12,490	$1,790.28	+$1.82M → APLIF
2	$312,726,966	$310,770,062.56	$16,522	$3,157.73	+$312.71M → APLIF
3	$49,997,862,140	$49,663,244,286.24	$23,578	$5,898.68	+$49997.84M → APLIF
4	$7,474,070,205,933	$7,420,572,493,443.65	$37,115	$11,886.75	+$7474070.17M → APLIF
5	$1,044,712,232,322,833	$1,036,714,977,202,484.10	$66,136	$26,423.57	+$1044712232.26M → APLIF
6	$136,547,911,758,351,100	$135,430,069,669,765,680.00	$137,257	$66,491.44	+$136547911758.21M → APLIF
7	$16,689,313,388,956,088,000	$16,543,207,123,374,653,000.00	$341,734	$194,868.54	+$16689313388955.75M → APLIF
8	$1,907,542,220,817,720,100,000	$1,889,684,655,491,537,200,000.00	$1,050,788	$685,133.02	+$1907542220817719.00M → APLIF
9	$203,896,877,423,206,970,000,000	$201,855,807,246,932,000,000,000.00	$4,099,314	$2,974,971.01	+$203896877423206976.00M → APLIF
10	$20,382,968,138,483,967,000,000,000	$20,164,798,479,641,134,000,000,000.00	$20,775,530	$16,389,263.41	+$20382968138483965952.00M → APLIF

APLIF vs GBDC: Complete Analysis 2026

APLIF — Stock

Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.

Full APLIF Calculator →

GBDC — BDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →

📬

Get this APLIF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APLIF vs SCHD APLIF vs JEPI APLIF vs O APLIF vs KO APLIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.